The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony Goncalves, Pascal Finetti, Daniel Birnbaum, François Bertucci
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Online Access:https://doaj.org/article/ecafbdc5cfd6482fbd26fa13182d387e
Tags: Add Tag
No Tags, Be the first to tag this record!